These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30596291)

  • 1. Chitosan-based nanotherapeutics for ovarian cancer treatment.
    Alizadeh L; Zarebkohan A; Salehi R; Ajjoolabady A; Rahmati-Yamchi M
    J Drug Target; 2019 Sep; 27(8):839-852. PubMed ID: 30596291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
    Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
    Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeting strategies for chitosan-based nanoparticles.
    Zhang X; Yang X; Ji J; Liu A; Zhai G
    Colloids Surf B Biointerfaces; 2016 Dec; 148():460-473. PubMed ID: 27665379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan is a potential inhibitor of ovarian cancer: Molecular aspects.
    Chamani M; Maleki Dana P; Chaichian S; Moazzami B; Asemi Z
    IUBMB Life; 2020 Apr; 72(4):687-697. PubMed ID: 31873986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2021; 16(2):249-257. PubMed ID: 33563157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
    Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
    Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.
    Rajitha P; Gopinath D; Biswas R; Sabitha M; Jayakumar R
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1177-94. PubMed ID: 27087148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
    Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
    Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of chitosan-based nanoparticles as drug delivery systems in pancreatic cancer.
    Sadoughi F; Mansournia MA; Mirhashemi SM
    IUBMB Life; 2020 May; 72(5):872-883. PubMed ID: 32057169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
    Tran TH; Nguyen TD; Poudel BK; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    AAPS PharmSciTech; 2015 Dec; 16(6):1307-16. PubMed ID: 25787869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting the dots in drug delivery: A tour d'horizon of chitosan-based nanocarriers system.
    Pramanik S; Sali V
    Int J Biol Macromol; 2021 Feb; 169():103-121. PubMed ID: 33338522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-Acrylic Polymeric Nanoparticles with Dynamic Covalent Bonds. Synthesis and Stimuli Behavior.
    Palacio H; Otálvaro F; Giraldo LF; Ponchel G; Segura-Sánchez F
    Chem Pharm Bull (Tokyo); 2017 Dec; 65(12):1132-1143. PubMed ID: 29021499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review.
    Suarato G; Li W; Meng Y
    Biointerphases; 2016 Dec; 11(4):04B201. PubMed ID: 27016506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.